Market Overview:
The global Albuterol Sulfate Metered Dose Inhalers market is expected to register a CAGR of 5.5% during the forecast period (2018-2030). The growth in the market can be attributed to factors such as rising prevalence of respiratory diseases, increasing awareness about asthma and COPD, and technological advancements in metered dose inhalers. Based on type, the global Albuterol Sulfate Metered Dose Inhalers market is segmented into 90 mcg, 108 mcg, and 120 mcg. Based on application, the market is segmented into kids and adults. Geographically, the global Albuterol Sulfate Metered Dose Inhalers market is segmented into North America, Latin America, Europe Asia Pacific and Middle East & Africa.
Product Definition:
Albuterol sulfate is a bronchodilator that relaxes the muscles in the airways and increases air flow to the lungs. Albuterol sulfate metered dose inhalers (MDIs) are used to prevent and treat bronchospasm ( narrowing of the airways), including asthma, chronic obstructive pulmonary disease (COPD), and other lung diseases.
90 mcg:
90 Mcg is the dosage of Albuterol Sulfate Metered Dose Inhalers. It's used for asthma and other respiratory disorders. The drug was first manufactured by Reckitt Benckiser in 1996 as an over-the-counter (OTC) medication, which was approved by the Food and Drug Administration (FDA) in 1997.
108 mcg:
Albuterol sulfate is a bronchodilator. Its mechanism of action is to open up the airways and allow oxygen to reach the blood cells more easily. It works by relaxing smooth muscles in the lungs, making it easier for air to pass through and bringing about a reduction in shortness of breath sensation.
Application Insights:
The adults segment held the largest share of more than 60.0% in 2017. Rising awareness regarding asthma and other allergic disorders is expected to increase the demand for albuterol sulfate metered dose inhalers (MDIs) among adult population, especially in North America and Europe. According to data published by CDC, around 35-50 million people suffer from asthma across the world, which is expected to boost product demand over the forecast period.
In addition, growing incidence of chronic bronchitis due to smoking prevalence has increased MDI usage rate among adults as well as kids population globally. In addition, increasing number of hospital admissions due to attacks of asthmatic nature are further anticipated to drive market growth over the forecast period globally.
Regional Analysis:
North America dominated the global albuterol sulfate metered dose inhalers market in 2017. This is attributed to the high prevalence of asthma and COPD, increasing awareness about CMDs, and availability of efficient treatment methods for these diseases. Moreover, an increase in FDA approvals for new products is also expected to drive growth during the forecast period. The U.S.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for Albuterol Sulfate Metered Dose Inhalers in the coming years.
- Growing awareness about asthma and its treatment: There is a growing awareness among people about asthma and its treatment options, which is expected to boost the demand for Albuterol Sulfate Metered Dose Inhalers in the near future.
- Technological advancements in inhalers: The technological advancements in inhalers are helping to improve their efficacy and patient compliance, thereby driving the growth of this market.
- Rising number of smokers: The number of smokers across the globe is rising at an alarming rate, which is likely to increase the incidence of respiratory diseases such as asthma and COPD, thereby propellingthe growth of this market during forecast period. 5) Expanding population base: The expanding population base across emerging economies offers a significant potential for growth for players operating in this market
Scope Of The Report
Report Attributes
Report Details
Report Title
Albuterol Sulfate Metered Dose Inhalers Market Research Report
By Type
90 mcg, 108 mcg, 120 mcg
By Application
Kids, Adults
By Companies
GSK, Merck, Teva, Orion Pharma, Par Pharmaceutical, Prasco, Shandong Jewim Pharma, Shanghai Sinepharm
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
192
Number of Tables & Figures
135
Customization Available
Yes, the report can be customized as per your need.
Global Albuterol Sulfate Metered Dose Inhalers Market Report Segments:
The global Albuterol Sulfate Metered Dose Inhalers market is segmented on the basis of:
Types
90 mcg, 108 mcg, 120 mcg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Kids, Adults
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GSK
- Merck
- Teva
- Orion Pharma
- Par Pharmaceutical
- Prasco
- Shandong Jewim Pharma
- Shanghai Sinepharm
Highlights of The Albuterol Sulfate Metered Dose Inhalers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 90 mcg
- 108 mcg
- 120 mcg
- By Application:
- Kids
- Adults
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Albuterol Sulfate Metered Dose Inhalers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Albuterol sulfate metered dose inhalers (MDIs) are a type of asthma medication that delivers a fixed dose of albuterol through the mouth. Albuterol MDIs are available in two strengths: 80 mcg and 120 mcg.
Some of the major players in the albuterol sulfate metered dose inhalers market are GSK, Merck, Teva, Orion Pharma, Par Pharmaceutical, Prasco, Shandong Jewim Pharma, Shanghai Sinepharm.
The albuterol sulfate metered dose inhalers market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Albuterol Sulfate Metered Dose Inhalers Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Albuterol Sulfate Metered Dose Inhalers Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Albuterol Sulfate Metered Dose Inhalers Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Albuterol Sulfate Metered Dose Inhalers Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Albuterol Sulfate Metered Dose Inhalers Market Size & Forecast, 2020-2028
4.5.1 Albuterol Sulfate Metered Dose Inhalers Market Size and Y-o-Y Growth
4.5.2 Albuterol Sulfate Metered Dose Inhalers Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 90 mcg
5.2.2 108 mcg
5.2.3 120 mcg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Kids
6.2.2 Adults
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Albuterol Sulfate Metered Dose Inhalers Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Albuterol Sulfate Metered Dose Inhalers Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 90 mcg
9.6.2 108 mcg
9.6.3 120 mcg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Kids
9.10.2 Adults
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 90 mcg
10.6.2 108 mcg
10.6.3 120 mcg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Kids
10.10.2 Adults
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 90 mcg
11.6.2 108 mcg
11.6.3 120 mcg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Kids
11.10.2 Adults
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 90 mcg
12.6.2 108 mcg
12.6.3 120 mcg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Kids
12.10.2 Adults
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 90 mcg
13.6.2 108 mcg
13.6.3 120 mcg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Kids
13.10.2 Adults
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Albuterol Sulfate Metered Dose Inhalers Market: Competitive Dashboard
14.2 Global Albuterol Sulfate Metered Dose Inhalers Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GSK
14.3.2 Merck
14.3.3 Teva
14.3.4 Orion Pharma
14.3.5 Par Pharmaceutical
14.3.6 Prasco
14.3.7 Shandong Jewim Pharma
14.3.8 Shanghai Sinepharm
